Massachusetts Governor Proposes Medical Debt Rules

Massachusetts Governor Maura Healey has proposed regulations that would effectively ban the reporting of medical debt to consumer credit bureaus by licensed health care providers and the debt collectors working on their behalf, positioning the Commonwealth at the forefront of state-level efforts to decouple medical bills from consumer credit scores. The proposed rules tie compliance directly to licensure, raising the stakes for hospitals, clinicians, and collection vendors and signaling a significant shift in how medical debt collection and credit reporting will operate in Massachusetts if finalized.

Overview of Healey’s Proposal

Healey’s announcement, made in late June 2026, unveiled draft regulations developed by the Massachusetts Department of Public Health (DPH) that would prohibit licensed health care providers and their collection vendors from reporting medical debt to consumer reporting agencies. The administration frames the move as part of a broader agenda to lower health care costs, protect patients from long-term financial harm, and ensure residents do not avoid care for fear of damaging their credit profiles.

At a Boston press conference hosted at the office of consumer advocacy group Health Care For All, Healey and DPH Commissioner Robbie Goldstein emphasized that medical debt can impede people’s ability to rent an apartment, purchase a home, or access affordable credit, and that those downstream effects are inconsistent with the state’s goals for health equity and economic opportunity. Healey first previewed her intention to pursue a ban on medical-debt credit reporting during her State of the Commonwealth address earlier in the year, and the June announcement marks the formal regulatory follow-through on that pledge.

Core Regulatory Mechanics

The proposed regulations would operate through the state’s health care licensure framework rather than directly amending credit reporting law. Under the draft rules, licensed health care facilities and professionals, as well as debt collectors acting on their behalf, would be barred from reporting medical debt to consumer credit agencies or entering contracts that require such reporting.

DPH has indicated that noncompliant providers could face licensure consequences, including potential suspension, revocation, or denial of facility or professional licenses, effectively making adherence a condition of doing business in Massachusetts. Goldstein has underscored that tying the prohibition to licensure gives the state meaningful enforcement leverage: if a provider or affiliated collector reports medical debt, “their license would be at risk,” whether that is the license of the facility or the individual practitioner.

Public Health Department Process and Timeline

DPH developed the proposed rules and secured approval from all 23 of its licensing boards to advance the regulations for public comment, indicating broad institutional backing within the state’s health regulatory apparatus. The department is accepting written public comments and has scheduled public hearings for July 27 and 28, after which officials will review feedback and finalize the regulations.

Media reporting indicates that the regulations are expected to be approved following the comment period, although final text and implementation timelines could be adjusted based on stakeholder input. Once effective, the rules would add a new compliance dimension for providers and collection vendors, which will need to ensure their contracts, data furnishing practices, and internal policies align with the prohibition on medical-debt reporting for Massachusetts accounts.

Alignment with Legislative Efforts

Healey’s regulatory push runs alongside and complements legislative activity on medical debt in Massachusetts, including efforts to bar medical debt from credit reports and address broader aspects of medical collections. State Rep. Bud Williams has championed a bill titled “An Act Relative to Medical Debt Exclusion from Creditor Reports” (H.476), which would explicitly prohibit consumer credit reports from including medical bills, charges, debts, payments, or collections related to medical services.

Separately, a broader bill, “An Act alleviating the burden of medical debt for patients and families” (H.419), would, among other provisions, prohibit medical creditors and medical debt collectors from reporting medical debt to consumer reporting agencies and from selling medical debt to debt buyers. That legislation also proposes limits on “extraordinary collection actions,” extended timelines before such actions can commence, reduced judgment interest rates on medical debt, and expanded exemptions for consumers’ property and wages in medical collections.

Support from the CFPB and Federal Context

The Consumer Financial Protection Bureau has previously signaled support for Massachusetts’ efforts to curb the credit reporting of medical bills, positioning the state’s initiatives within a broader federal scrutiny of medical-debt reporting. In a January 2025 letter regarding state measures HD 3503 and SD 1878, the CFPB endorsed proposals that would prohibit medical creditors and debt collectors from reporting medical debt to consumer reporting agencies and bar those agencies from including such debt on consumer reports.

The CFPB has argued nationally that medical billing and collections often involve complex insurance disputes and billing errors, making medical debt an unreliable indicator of creditworthiness and a poor basis for underwriting decisions. Massachusetts’ regulatory proposal thus dovetails with a broader trend of federal and state actors questioning whether medical debt should play any role in consumer credit scoring, especially as major credit bureaus have already taken voluntary steps to reduce but not eliminate medical debt from reports.

Scope of Medical Debt Burden in Massachusetts

State officials have highlighted data indicating that roughly 1 in 8 residents in Massachusetts currently carry medical debt, and many others delay seeking treatment because of concerns that unpaid bills could harm their credit. A research brief by the Massachusetts Center for Health Information and Analysis has documented meaningful sociodemographic disparities in medical debt burden, with higher rates concentrated among lower-income households and certain racial and ethnic groups.

Healey’s framing explicitly ties the proposed regulations to efforts to reduce those disparities, arguing that removing medical debt from credit reports will alleviate a barrier that disproportionately affects vulnerable communities. Advocacy organizations have also underscored that medical debt often stems from unexpected emergencies and insurance complexities, rather than traditional “credit-seeking” behavior, further undermining its value as a predictive credit variable.

Implications for Providers and Debt Collectors

For health care providers, the regulations would require a review of contracts with third‑party collectors, revenue-cycle vendors, and any data furnishing arrangements that might involve credit reporting. Providers may need to ensure that their business associate agreements and statements of work explicitly prohibit medical-debt reporting in Massachusetts cases, and they will likely need to update internal compliance policies, staff training, and oversight processes accordingly.

Debt collectors working on behalf of Massachusetts licensed providers would need to adjust collection strategies to operate without the leverage of potential credit reporting on medical accounts, focusing instead on communication, payment plans, and other lawful collection tools. Agencies active across multiple states will have to segment Massachusetts accounts in their systems, implement logic to prevent furnishing of medical tradelines to consumer reporting agencies, and maintain records demonstrating compliance in the event of regulatory inquiry.

Interaction with Existing Collection and Credit Reporting Rules

The proposed regulations would overlay existing state and federal frameworks, including the Fair Debt Collection Practices Act, the Fair Credit Reporting Act, and Massachusetts’ own debt collection and consumer protection laws. While the FDCPA and FCRA govern how debt collection and credit reporting occur, Massachusetts’ approach would effectively remove one key tool—credit reporting—entirely from the collection toolkit for medical accounts tied to licensed providers in the state.

If the broader medical-debt bill H.419 advances, medical collectors in Massachusetts could also face new limits on extraordinary collection actions, tighter timing rules around when such actions can be taken, and enhanced protections for consumers whose medical charges are still subject to insurance appeals or internal reviews. Those legislative provisions, combined with Healey’s regulatory ban on reporting, would further differentiate medical debt from other consumer obligations in Massachusetts, creating a distinct compliance regime for medical accounts.

Consumer Credit and Market Effects

For consumers, the most immediate effect of the proposed regulations would be that medical debts owed to licensed Massachusetts providers, or to collectors working for them, would no longer generate negative tradelines on credit reports, reducing the risk that an illness or injury will undermine their ability to obtain housing, auto loans, or other forms of credit. Healey and supporters argue this change will relieve pressure on residents who might otherwise avoid needed care, knowing that an unpaid bill could follow them for years through damaged credit scores.

From a market perspective, critics may raise concerns that removing medical debt from credit files could affect lenders’ risk assessments or lead to cost-shifting in the form of higher prices or more aggressive non‑credit‑reporting collection tactics. However, regulators and consumer advocates counter that medical debt’s predictive value is limited and that many lenders already rely heavily on non‑medical tradelines and alternative data, while major national bureaus have already begun restricting medical debt reporting voluntarily.

What to Watch Next

Key milestones for industry stakeholders include the DPH public hearings on July 27–28 and the subsequent release of final regulatory text, which will clarify effective dates, enforcement expectations, and any carve‑outs or implementation phases. Providers, agencies, and credit furnishers should monitor how the final rules address issues such as legacy accounts, disputes, and the treatment of third‑party financing products marketed for medical services, as related legislative efforts in Massachusetts already define “medical debt” broadly to include certain medical credit products.

In parallel, the trajectory of H.476 and H.419 on Beacon Hill will be important in determining whether Massachusetts ultimately regulates medical debt primarily through health-care licensure, direct credit-reporting prohibitions, or a combination of both. Given the CFPB’s expressed support and ongoing national scrutiny of medical-debt reporting, developments in Massachusetts are likely to be watched closely by other states and by national creditors and collectors evaluating whether similar changes may emerge in additional jurisdictions.